Effects of Glucagon-Like Peptide-1 in Patients with Acute Myocardial Infarction and Left Ventricular Dysfunction after Successful Reperfusion

Circulation

Volumn 109, Issue 8, 2004, Pages 962-965

  Nikolaidis, Lazaros A ^a   Mankad, Sunil ^a   Sokos, George G ^a   Miske, Glen ^a   Shah, Ankur ^a   Elahi, Dariush ^b   Shannon, Richard P ^a  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Angioplasty; Heart failure; Insulin; Myocardial infarction

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; GLUCOSE;

ACUTE HEART INFARCTION; ADULT; AGED; APPETITE DISORDER; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DRUG EFFECT; DRUG EFFICACY; DRUG INFUSION; DRUG SAFETY; DRUG TOLERABILITY; ECHOCARDIOGRAPHY; FEMALE; GASTROINTESTINAL SYMPTOM; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE REPERFUSION; HUMAN; HYPOGLYCEMIA; MALE; NAUSEA; PRIORITY JOURNAL; SCORING SYSTEM; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD GLUCOSE; COMBINED MODALITY THERAPY; DIABETES COMPLICATIONS; FEMALE; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-LIKE PEPTIDES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PEPTIDE FRAGMENTS; PILOT PROJECTS; SAFETY; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 1442311383     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000120505.91348.58     Document Type: Article

References (15)

1. Apstein CS, Tagtmeyer H. Glucose-insulin-potassium in acute myocardial infarction. Circulation. 1997;96:1074-1077.
2. Diaz R, Paolasso EA Piegas LS, et al. Metabolic modulation of acute myocardial infarction: the ECLA glucose-insulin-potassium pilot trial. Circulation. 1998;98:2227-2234.
3. Apstein CS. Glucose-insulin-potassium for acute myocardial infarction: remarkable results from a new prospective, randomized trial. Circulation. 1998;98:2223-2226.
4. Satler LF, Green CE, Kent KM, et al. Metabolic support during coronary reperfusion. Am Heart J. 1987;102:1038-1049.
5. Taegtmeyer H, deVillalobos DH. Metabolic support for the post-ischemic heart. Lancet. 1995;345:1552-1555.
6. Opie LH. Proof that glucose-insulin-potassium provides metabolic protection of ischemic myocardium. Lancet. 1999;353:768-769.
7. Sack MN, Yellon CM. Insulin therapy as an adjunct to reperfusion after acute coronary ischemia. J Am Coll Cardiol. 2003;41:1404-1407.
8. Van der Horst IC, Zijlstra F, vant Hof AW, et al. Glucose-insulin-potassium infusion in patients treated with primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2003;42:784-791.
9. Drucker DJ. Glucagon-like peptides. Diabetes. 1998;47:159-169.
10. D'Alessio DA, Kahn SE, Leusner CR, et al. Glucagon-like peptide 1 enhances glucose tolerance by stimulation of insulin release and by increasing insulin-independent glucose disposal. J Clin Invest. 1994;93: 2263-2266.
11. Ritzel R, Orskov C, Holst JJ, et al. Pharmacokinetic, insulinotropic and glucagonostatic properties of GLP-1 [7-36] amide after subcutaneous injection in healthy volunteers. Diabetologia. 1995;38:720-725.
12. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr. 1989;2:358-367.
13. Malmberg K, Ryden L, Effendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol. 1995;26:57-65.
14. Kavianipour M, Ehlers MR, Malmberg K, et al. Glucagon-like peptide-1(7-36) amide prevents the accumulation of pyruvate and lactate in ischemic and non-ischemic myocardium. Peptides. 2003;24:569-578.
15. Leaf A, Kang JX, Xiao YF, et al. Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation. 2003;107:2646-2652.